Abstract
Facing lawsuits from all the states and others, Mallinckrodt last week filed Chapter 11 to resolve opioid‐related claims, as well as other claims. Its businesses, including operations for opioid use disorder (OUD) medications methadone and buprenorphine, will continue to supply products to patients and customers.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
